Efficacy of Pregabalin for Patients With Irritable Bowel Syndrome | MicrobiomeTrials← Back to trialsNCT07635394
Efficacy of Pregabalin for Patients With Irritable Bowel Syndrome
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-04-07Est. Completion: 2026-04-08
Enrollment target: 258 participants Locations- Beijing Tiantan Hospital, Beijing, Beijing Municipality, China
Other microbiome trials you might be interested in
Functional Gastrointestinal Disorders (FGID)
Brief Summary
Functional gastrointestinal disorders (FGID), including irritable bowel syndrome (IBS), are common condit…
Multiple LocationsEst. completion Sep 1, 2027
Ulcerative ColitisHealthyIrritable Bowel Syndrome With Diarrhea
This trial is being completed to learn about how Aquamin® affects gastrointestinal permeability, or the control of mater…
Ann Arbor, United StatesCompleted Mar 11, 2024